The effect of interferon on rabies infection of animals.
D000818:Animals; D002266:Carboxymethylcellulose Sodium / Q000008:administration & dosage / Q000627:therapeutic use* / Q000031:analogs & derivatives; D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000096:biosynthesis; D008253:Macaca mulatta; D008747:Methylcellulose / Q000031:analogs & derivatives*; D051379:Mice; D010455:Peptides / Q000627:therapeutic use*; D011070:Poly I-C / Q000008:administration & dosage / Q000627:therapeutic use*; D011107:Polylysine / Q000008:administration & dosage / Q000627:therapeutic use* / Q000031:analogs & derivatives; D011818:Rabies / Q000276:immunology / Q000628:therapy*; D011819:Rabies Vaccines / Q000008:administration & dosage
D010455:Peptides; D011819:Rabies Vaccines; D011107:Polylysine; C019531:poly ICLC; D008747:Methylcellulose; D007372:Interferons; D002266:Carboxymethylcellulose Sodium; D011070:Poly I-C